Feed / NBIX

Neurocrine Biosciences, Inc.

NBIX

Healthcare · 153.34 +0.2% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Neurocrine Biosciences, Inc.'s current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 11 directly disclosed connections are confirming.

What changed
  • Revenue increased 42.2% versus the comparable filing period.
Company+0.2% todayVolume comparison unavailable
Market group0 of 9 activeBiotechnology · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Q1 2026 total net product sales rose $247.3M (43.9%) to $811.0M, driven by CRENESSITY launch and INGREZZA volume growth and record new prescriptions.

Invalidation: The isolated read changes if NBIX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind NBIX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ABBVAbbVie Inc.partnerFeb 11, 2026

Our partner AbbVie received FDA approval for ORILISSA for endometriosis in July 2018 and for ORIAHNN for uterine fibroids in May 2020.

TAKTakeda Pharmaceutical Company LimitedpartnerFeb 11, 2026

Some of our other collaborators include Nxera Pharma UK Limited (formerly Sosei Heptares), Takeda Pharmaceutical Company Limited, Voyager Therapeutics, Inc., and Xenon Pharmaceuticals Inc.

Depended on by

XENEXenon Pharmaceuticals Inc.partnerMay 7, 2026

Our Partnered Program with Neurocrine Biosciences In December 2019, we entered into a license and collaboration agreement with Neurocrine Biosciences to develop treatments for epilepsy.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

NBIX is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.